When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CDTX - Cidara up 77% premarket on rezafungin development deal
Cidara Therapeutics Inc.
Thinly traded nano cap Cidara Therapeutics (NASDAQ:CDTX) is up 77% premarket on increased volume, albeit in turnover of only 92K shares, in response to its agreement with Mundipharma to develop and commercialize rezafungin, a once-weekly echinocandin antifungal, for the first-line treatment of candidemia and invasive candidiasis and the prophylaxis of invasive fungal infections in patients undergoing allogeneic blood and marrow transplantations.
More news on: Cidara Therapeutics, Inc., Healthcare stocks news, Stocks on the move,